10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
GILEAD SCIENCES, INC. | ||
Ticker: GILD Fiscal Year: 2012 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2012 10-K (Filed: Feb 27, 2013) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2012 | Dec 31, 2011 | |
| Assets [Abstract] | ||
| Cash and Cash Equivalents | $ 1,803,694 | 9,883,777 |
| Short-Term Marketable Securities | 58,556 | 16,491 |
| Accounts Receivable, Net of Allowances of $261,013 at December 31, 2012 and $205,990 at December 31, 2011 | 1,751,388 | 1,951,167 |
| Inventories | 1,744,982 | 1,389,983 |
| Deferred Tax Assets | 262,641 | 208,155 |
| Prepaid Taxes | 348,420 | 246,444 |
| Prepaid Expenses and Other Current Assets | 186,666 | 222,768 |
| Total Current Assets | 6,156,347 | 13,918,785 |
| Property, Plant and Equipment, Net | 1,100,259 | 774,406 |
| Long-Term Portion of Prepaid Royalties | 175,790 | 174,584 |
| Long-Term Deferred Tax Assets | 131,107 | 144,015 |
| Long-term Marketable Securities | 719,836 | 63,704 |
| Intangible Assets, Net | 11,736,393 | 1,062,864 |
| Goodwill | 1,060,919 | 1,004,102 |
| Other Long-Term Assets | 159,187 | 160,674 |
| Total Assets | 21,239,838 | 17,303,134 |
| Liabilities and Stockholders' Equity [Abstract] | ||
| Accounts Payable | 1,327,339 | 1,206,052 |
| Accrued government rebates | 745,148 | 547,473 |
| Accrued Compensation and Employee Benefits | 236,716 | 173,316 |
| Income Taxes Payable | 13,403 | 40,583 |
| Other Accrued Liabilities | 674,762 | 471,129 |
| Deferred Revenues | 103,162 | 74,665 |
| Current Portion of Long-Term Debt and Other Obligations, net | 1,169,490 | 1,572 |
| Total Current Liabilities | 4,270,020 | 2,514,790 |
| Long-Term Deferred Revenues | 20,532 | 31,870 |
| Long-Term Debt, net | 7,054,555 | 7,605,734 |
| Long-Term Income Taxes Payable | 115,822 | 135,655 |
| Other Long-Term Obligations | 228,040 | 147,736 |
| Stockholders' Equity [Abstract] | ||
| Preferred Stock, Par Value $0.001 Per Share; 5,000 Shares Authorized; None Outstanding | 0 | 0 |
| Common Stock, Par Value $0.001 Per Share; 2,800,000 Shares Authorized; 1,519,163 and 1,506,212 Shares Issued and Outstanding at December 31, 2012 and December 31, 2011, Respectively | 760 | 753 |
| Additional Paid-in Capital | 5,649,850 | 4,903,143 |
| Accumulated Other Comprehensive Income (Loss) | (45,615) | 58,200 |
| Retained Earnings | 3,704,744 | 1,776,760 |
| Total Gilead Stockholders' Equity | 9,309,739 | 6,738,856 |
| Noncontrolling Interest | 241,130 | 128,493 |
| Total Stockholders' Equity | 9,550,869 | 6,867,349 |
| Total Liabilities and Stockholders' Equity | 21,239,838 | 17,303,134 |
| External Links | |
| GILEAD SCIENCES, INC. (GILD) Fiscal Year 2012 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |